Cinctive Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,864
Closed -$1.23M 604
2021
Q4
$1.23M Sell
5,864
-5,206
-47% -$1.08M 0.05% 376
2021
Q3
$2.13M Sell
11,070
-14,848
-57% -$3.65M 0.1% 286
2021
Q2
$7.33M Buy
25,918
+18,655
+257% +$5.06M 0.34% 80
2021
Q1
$1.54M Sell
7,263
-8,261
-53% -$1.98M 0.09% 292
2020
Q4
$3.05M Buy
+15,524
New +$2.74M 0.25% 169

Other funds holding MED

Cinctive Capital Management's MED Position: Q1 2022 in Review

Cinctive Capital Management sold out of Medifast (MED) in Q1 2022, closing a stake of 5,864 shares — an estimated $1.23M sold.

Cinctive Capital Management first reported a position in MED in Q4 2020 and held it in 5 quarters. The position peaked at $7.33M in Q2 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Cinctive Capital Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 5,864 Medifast shares in Q1 2022, an estimated $1.23M.
  • Cinctive Capital Management first reported a position in Medifast in Q4 2020 and held it in 5 quarters.
  • Cinctive Capital Management's Medifast position peaked at $7.33M in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Cinctive Capital Management's 13F filing for Q1 2022, filed 16 May 2022.